At least 12 countries, there were cases of narcolepsy in children who had been vaccinated against influenza A
08/02/1911 - 14:42
This was confirmed by the WHO. The children had received vaccinations Pandemirx brand. WHO itself had donated 36 million doses to 18 developing countries, including Cuba and Bolivia.
World Health Organization (WHO) announced today that at least 12 countries reported cases of narcolepsy in children and adolescents who had previously been vaccinated against influenza A.
The Global Advisory Committee on Vaccine Safety, WHO issued a statement specifying that "since August 2010, following massive vaccination against influenza virus H1N1 in 2009, there were cases of narcolepsy in children and adolescents in at least 12 countries. "
Narcolepsy is a disease state that occurs in the affected access irresistible sleep at any time.
WHO spokeswoman, Alison Brunier, failed to answer at a press conference today what the countries that have been detected cases of narcolepsy. Could not confirm whether or not that information is public domain.
The Committee said it takes "more research" to determine the exact relationship between cases of narcolepsy and influenza vaccination, the vaccine is Pandemrix (manufacturer GlaxoSmithKline) or other purposes.
WHO has donated 36 million doses of vaccine, "Pandemrix" to 18 developing countries, but so far not been heard of who have been cases of narcolepsy.
The list of countries receiving "Pandemrix" is the following: Armenia, Azerbaijan, Bangladesh, Bolivia, Burkina Faso, Cuba, North Korea, El Salvador, Ethiopia, Ghana, Namibia, Philippines, Tajikistan, Togo, Rwanda, Kenya, Mongolia and Senegal.
On the other hand, last week, WHO announced it was investigating a rise in cases of narcolepsy in Finland which could be associated with the vaccine Pandemrix affected since all appeared to have been immunized with the same product. Brunier
specified that although almost all cases had been vaccinated with Pandemrix research is not excluded in cases where patients have been immunized with another brand.
According to this study, between 2009 and 2010 were diagnosed 60 cases of narcolepsy in Finnish children and adolescents between 4 and 19, which 52 (almost 90 per cent) had been vaccinated with this brand of vaccine.
turn, in Helsinki, the National Institute of Health and Welfare of Finland (THL) published a study showing that the H1N1 flu vaccine Pandemrix multiplies the risk of childhood narcolepsy.
This led to the Finnish health authorities to stop using this vaccine as a preventive measure to determine their possible side effects.
However, WHO considers that there are no conclusive studies to remove the vaccine market. Even encouraged to continue vaccinating countries. According Brunier said, "The risk-benefit of getting the flu against the possibility of narcolepsy shows that it is better keep immunizing. "
The European Centre for Disease Control (ECDC) is currently conducting epidemiological studies on the relationship between narcolepsy and vaccines against H1N1 influenza.
" These studies may help clarify whether there is a increased risk of narcolepsy, which currently appears to be restricted to the months after vaccination and by age and country, "said the statement from the Committee.
The completed final report on the relationship between narcolepsy and this vaccine will be distributed to 31 next August.
SOURCE: EFE
http://www.clarin.com/sociedad/salud/paises-narcolepsia-chicos-vacunados-gripe_0_423557846.html
